2021 BAA for Development of Medical Countermeasures for Biological Threats

Global Biodefense  March 2, 2021
The National Institute of Allergy and Infectious Diseases (NIAID) solicitation contains multiple distinct Research Areas. The goal of Research Area 1 is to advance vaccine technologies and platforms which could be deployed against agents important for biodefense and/or emerging pathogens. Pathogens of particular interest include (but are not limited to): Burkholderia spp, Francisella tularensis, Yersinia pestis, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Candida auris. A second objective is to support development of vaccines for emerging viruses and pandemic preparedness. Targets of particular interest include: Vaccines that target coronaviruses with pandemic potential, Development of pan-coronavirus (pan-CoV) vaccine candidates that provide durable protective immunity to multiple CoV strains. Eastern equine encephalitis virus (EEEV), Tick borne viruses, Non-Zaire Ebolaviruses/filoviruses (such as SUDV, MARV).¬† The proposal deadline is May 24, 2021. BAA¬†…read more.

Posted in Biodefense and tagged .

Leave a Reply